The PCR result showed that during the development of NAFLD, the expression of VEGF-C in liver demonstrated an upward trend, which was significantly different from the control group at 16 and 24 weeks HFD. Here, VEGFC is linked to metabolic dysfunction-associated steatotic liver disease.